CMS

FDA approves breakthrough cancer gene testFDA approved a new cancer biomarker test that can detect genetic mutations in 324 genes and 2 genomic signatures in tumors.
Federal program aimed at reducing readmissions raises concernsA new study has shocking findings about death rates in heart failure patients enrolled in the Hospital Readmissions Reduction Program.
Five approaches to effective cancer care managementManaging the care for members with cancer is unlike managing care for other chronic diseases. Here’s five ways to better care for cancer patients.
CMS plan to slash 340B payments under fire by hospitalsHere are four ways CMS’ final rule related to the 340B Drug Pricing Program could affect the healthcare industry.
Do accountable care organizations save money?New data from CMS show that ACOs succeed at producing quality gains and cost savings, but at least one effort begs to differ.
Meeting the ‘status quo’ with CMS Star Ratings equals regressionCMS’ 5-Star Rating system requires proactive intervention to improve patient medication adherence, and leaves plans with little room to rest on their laurels.
Many hospitals not sharing e-patient dataWhy researchers say the industry is “a long way off” from robust electronic patient data sharing.
Five key findings from health executive value-based care surveyA survey from HealthScape Advisors and the Health Plan Alliance has revealing findings about value-based payment models.
Five rules for payer success in oncologyPayers must reinvent efforts to reduce cancer cost and increase quality for a value-based care world. Here’s five rules to follow.
CMS quality payment program year 2 proposal: 8 things to knowCMS’ Quality Payment Program launched in 2016 as part of MACRA. Here’s what’s in store for Year 2.